Your browser doesn't support javascript.
loading
Flame-Made Calcium Phosphate Nanoparticles with High Drug Loading for Delivery of Biologics.
Tsikourkitoudi, Vasiliki; Karlsson, Jens; Merkl, Padryk; Loh, Edmund; Henriques-Normark, Birgitta; Sotiriou, Georgios A.
Affiliation
  • Tsikourkitoudi V; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-1 71 77 Stockholm, Sweden.
  • Karlsson J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-1 71 77 Stockholm, Sweden.
  • Merkl P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-1 71 77 Stockholm, Sweden.
  • Loh E; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-1 71 77 Stockholm, Sweden.
  • Henriques-Normark B; Lee Kong Chian School of Medicine (LKC) and Singapore Centre on Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, Singapore 639798, Singapore.
  • Sotiriou GA; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-1 71 77 Stockholm, Sweden.
Molecules ; 25(7)2020 Apr 10.
Article in En | MEDLINE | ID: mdl-32290273
Nanoparticles exhibit potential as drug carriers in biomedicine due to their high surface-to-volume ratio that allows for facile drug loading. Nanosized drug delivery systems have been proposed for the delivery of biologics facilitating their transport across epithelial layers and maintaining their stability against proteolytic degradation. Here, we capitalize on a nanomanufacturing process famous for its scalability and reproducibility, flame spray pyrolysis, and produce calcium phosphate (CaP) nanoparticles with tailored properties. The as-prepared nanoparticles are loaded with bovine serum albumin (model protein) and bradykinin (model peptide) by physisorption and the physicochemical parameters influencing their loading capacity are investigated. Furthermore, we implement the developed protocol by formulating CaP nanoparticles loaded with the LL-37 antimicrobial peptide, which is a biological drug currently involved in clinical trials. High loading values along with high reproducibility are achieved. Moreover, it is shown that CaP nanoparticles protect LL-37 from proteolysis in vitro. We also demonstrate that LL-37 retains its antimicrobial activity against Escherichia coli and Streptococcus pneumoniae when loaded on nanoparticles in vitro. Therefore, we highlight the potential of nanocarriers for optimization of the therapeutic profile of existing and emerging biological drugs.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Biological Products / Calcium Phosphates / Drug Carriers / Drug Delivery Systems / Nanoparticles Type of study: Guideline Limits: Humans Language: En Journal: Molecules Journal subject: BIOLOGIA Year: 2020 Type: Article Affiliation country: Sweden

Full text: 1 Database: MEDLINE Main subject: Biological Products / Calcium Phosphates / Drug Carriers / Drug Delivery Systems / Nanoparticles Type of study: Guideline Limits: Humans Language: En Journal: Molecules Journal subject: BIOLOGIA Year: 2020 Type: Article Affiliation country: Sweden